首页> Leukemia & lymphoma> Increased risk of adverse acute myeloid leukemia after anti-CD19-targeted immunotherapies in <i>KMT2A</i>-rearranged acute lymphoblastic leukemia: a case report and review of the literature.

Increased risk of adverse acute myeloid leukemia after anti-CD19-targeted immunotherapies in <i>KMT2A</i>-rearranged acute lymphoblastic leukemia: a case report and review of the literature.

导出 LinkOut

翻译打印收藏纠错

第一作者： Elise,Fournier

第一单位： a Laboratory of Hematology , CH Dunkerque , Dunkerque , France.;b Laboratory of Hematology , CHU Lille , Lille , France.

作者： Elise,Fournier ^[1] ; Luca,Inchiappa ^[2] ; Carole,Delattre ^[3] ; Jean-Michel,Pignon ^[2] ; Frédérique,Danicourt ^[4] ; Maxime,Bemba ^[2] ; Catherine,Roche-Lestienne ^[5] ; Agnès,Daudignon ^[6] ; Gauthier,Decool ^[7] ; Christophe,Roumier ^[7] ; Florent,Dumezy ^[7] ; Loïc,Fournier ^[3] ; Nathalie,Grardel ^[7] ; Claude,Preudhomme ^[7] ; Nicolas,Duployez ^[7]

作者单位： a Laboratory of Hematology , CH Dunkerque , Dunkerque , France.;b Laboratory of Hematology , CHU Lille , Lille , France. ^[1] c Hematology Department , CH Dunkerque , Dunkerque , France. ^[2] a Laboratory of Hematology , CH Dunkerque , Dunkerque , France. ^[3] d Pharmacology Department , CH Dunkerque , Dunkerque , France. ^[4] e Department of Medical Genetics , CHU Lille , Lille , France.;f INSERM UMR-S 1172 , University of Lille , Lille , France. ^[5] e Department of Medical Genetics , CHU Lille , Lille , France. ^[6] b Laboratory of Hematology , CHU Lille , Lille , France.;f INSERM UMR-S 1172 , University of Lille , Lille , France. ^[7]